Owner GENETIX PHARMACEUTICALS, INC.

Inventors LEBOULCH, Philippe; WESTERMAN, Karen

Pub. Number AU-A-2002254775

PCT Pub. Number WO2002/087341

Priority 60/288,042 01.05.01 US

Filing date 1 May 2002

Wipo publication date 11 November 2002

A01N 063/00 Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 039/21 Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

C12N 005/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 015/74 Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors